The level of which one of the following compounds is elevated in bronchial asthama
**Core Concept**
In bronchial asthma, there is a complex interplay of airway inflammation, hyperresponsiveness, and remodeling. One key compound involved in this process is leukotriene C4 (LTC4), a potent bronchoconstrictor produced by the 5-lipoxygenase pathway in mast cells and eosinophils.
**Why the Correct Answer is Right**
The 5-lipoxygenase pathway is responsible for the conversion of arachidonic acid to leukotriene A4 (LTA4), which is then converted to LTC4 by the enzyme LTC4 synthase. LTC4 is a cysteinyl leukotriene that binds to the cysteinyl leukotriene receptor 1 (CysLT1R) on airway smooth muscle cells, leading to bronchoconstriction and increased mucus production. Elevated levels of LTC4 are found in the bronchoalveolar lavage fluid of patients with asthma, and its levels correlate with disease severity.
**Why Each Wrong Option is Incorrect**
* **Option A:** While histamine is a key mediator in allergic reactions, its levels are not specifically elevated in bronchial asthma. Histamine is involved in the early phase of allergic responses, whereas LTC4 is more relevant to the late phase.
* **Option B:** Prostaglandin D2 (PGD2) is a bronchoconstrictor produced by mast cells, but its levels are not as strongly associated with asthma as LTC4. PGD2 is more involved in the regulation of sleep and fever.
* **Option C:** Thromboxane A2 (TXA2) is a potent vasoconstrictor produced by platelets, but its levels are not directly related to bronchial asthma. TXA2 is more involved in platelet aggregation and vasoconstriction.
* **Option D:** Platelet-activating factor (PAF) is a phospholipid mediator involved in allergic responses, but its levels are not specifically elevated in bronchial asthma. PAF is more involved in platelet activation and inflammation.
**Clinical Pearl / High-Yield Fact**
In asthma, the use of leukotriene modifiers, such as montelukast, can help reduce symptoms by blocking the action of cysteinyl leukotrienes on the CysLT1R receptor.
**Correct Answer:** C. Leukotriene C4 (LTC4)